
|Videos|September 17, 2021
Dr. Matulewicz discusses underreported smoking status in GU cancer trials
Author(s)Urology Times staff
Advertisement
In this video, Richard Matulewicz, MD, MS, explains potential factors in underreported smoking status for GU cancer patients in clinical trials. Matulewicz is an assistant professor in the department of urology at Memorial Sloan Kettering Cancer Center, New York City.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Testosterone deficiency: FAQs from the AUA guideline
2
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
3
From hype to practice: Urologists assess AI's real impact
4
PTEN Testing Strategies for Newly Diagnosed mHSPC
5












